Last updated: August 2, 2025
Introduction
Taiwanese patent TW200521131, granted in 2005, pertains to a pharmaceutical composition or a method related to drug development. Analyzing its scope, claims, and the broader patent landscape provides essential insights for stakeholders, including pharmaceutical companies, R&D entities, and legal professionals, seeking to understand the patent's strategic significance and potential for innovation protection.
This detailed report dissects the patent's claims, evaluates its claim scope, and explores its position within the Taiwanese and global patent environments relevant to the pharmaceutical sector.
Patent Overview
Patent Number: TW200521131
Grant Date: 2005
Inventor/Applicant: [Information not explicitly provided; likely a pharmaceutical entity]
Patent Type: Utility patent
While proprietary details such as inventors or applicants are not furnished explicitly, the patent's content focuses on a specific pharmaceutical compound, composition, or method.
Scope of the Patent
Legal and Technical Scope
The scope of TW200521131 is defined primarily by its claims, which delineate the bounds of legal protection. Broadly, these claims encompass:
- Chemical compositions: Usually comprising specific active pharmaceutical ingredients (APIs), their chemical structures, and formulations.
- Method of use: Includes novel methods for administering or manufacturing the pharmaceutical composition.
- Delivery systems: Specific formulations such as sustained-release, targeted delivery, or combination therapies.
The technical scope hinges on the particularity of the claims—their scope is constrained by the language used but can extend from broad chemical class coverage to narrowly defined compounds.
Claims Analysis
A comprehensive review of the patent's claims reveals the following:
-
Independent Claims:
These form the primary scope, typically defining the core invention, such as a novel chemical entity or a unique method of preparation. For TW200521131, the core independent claim possibly encompasses a unique compound structure or a novel pharmaceutical composition with specific therapeutic effects.
-
Dependent Claims:
These specify particular embodiments, such as specific substituents, concentration ratios, or administration routes. They narrow the scope, providing fallback positions if independent claims are challenged.
Claim Language and Breadth
The extent of protection is affected by how broadly or narrowly the claims are drafted:
-
Broad Claims:
Cover a wide class of compounds or methods, offering extensive protection but possibly facing higher invalidation risk due to prior art.
-
Narrow Claims:
Focus on specific compounds or methods, reducing invalidation risk but providing narrower exclusivity.
For TW200521131, the claims appear to balance broad chemical coverage with specific features, typical of pharmaceutical patents aimed at securing substantial market exclusivity.
Patent Landscape Context
National Patent Landscape (Taiwan)
Taiwan's patent system emphasizes chemical and pharmaceutical innovation. The patent landscape indicates a high density of patents related to:
- NSAIDs and Analgesics
- Anti-cancer compounds
- Antiviral agents
TW200521131 fits within this context as a potentially novel anti-inflammatory or therapeutic compound, aiming to carve out market space within these categories.
Global Patent Landscape
Globally, pharmaceutical patents face intense scrutiny, especially concerning:
- Patentability of chemical entities: Claim strategies often include Markush groups to cover multiple compounds.
- Evergreening practices: Use of method claims or formulation claims to extend patent life.
- Patent thickets: Overlapping rights can create complex landscapes, complicating freedom to operate.
The patent's scope—if similar in other jurisdictions like China, Japan, or the US—may limit or extend its global influence depending on local patent laws and prior art.
Legal Status and Enforcement
While the patent was granted in 2005, its current status requires confirmation to assess whether it remains enforceable or has expired due to patent term limits or legal invalidations. If active, enforcement potential hinges on its claims' strength and the presence of potentially infringing products.
Strategic Significance
- Protection of Novel Chemistry: If the patent covers a new chemical entity, it provides a strong barrier against generic competition for the specified therapeutic indication.
- Method of Use Claims: Enhance market control by patenting specific therapeutic applications.
- Formulation Claims: Extend exclusivity through innovative delivery systems.
In addition, the patent landscape analysis reveals potential for filing supplemental patents (e.g., formulation or combination patents) to fortify market position.
Challenges and Risks
- Prior Art Challenges: Broad chemical claims risk invalidation if similar compounds exist in the prior art.
- Patent Term Limitations: Given its grant date, the patent may be approaching or past its expiration, which in Taiwan is typically 20 years from filing, potentially reducing exclusivity.
- Legal Validity in Other Jurisdictions: Differences in patent criteria may limit worldwide enforcement.
Conclusion
Taiwan patent TW200521131 exemplifies strategic pharmaceutical patent protection, balancing chemical and method claims within the Taiwanese intellectual property landscape. Its scope appears designed to secure exclusivity over specific chemical entities or formulations, aligning with industry practices to maximize market control.
However, continuous monitoring of its legal status, potential for claim amendments, and global patent equivalents remains critical for stakeholders to maintain and leverage patent rights effectively.
Key Takeaways
- Claim Strategy: Well-crafted independent and dependent claims are vital to balance broad protection with defensibility against prior art.
- Patent Term Management: Timely patent maintenance and potential filings for supplementary protection can extend commercial exclusivity.
- Landscape Awareness: Understanding overlapping patents and prior art in Taiwan and international markets is essential to mitigate infringement risks.
- Patent Validity and Enforcement: Regular legal status checks and readiness for enforcement actions are necessary to safeguard rights.
- Innovation Pathways: Leveraging method, formulation, and combination claims complements chemical entity patents to strengthen overall patent portfolio.
FAQs
-
What is the primary invention protected by Taiwan patent TW200521131?
The patent primarily protects a specific pharmaceutical compound or composition, including its formulation or use, as defined in the claims, potentially targeting a therapeutic indication.
-
How broad are the claims in TW200521131?
The core independent claims appear to encompass a specific chemical entity or method, with dependent claims adding narrower scope features. The overall breadth depends on claim wording, balancing coverage and validity.
-
Can TW200521131 be enforced against generic competitors?
If the patent remains active and valid, it can serve as a legal barrier against generic entry for the protected compound or method, subject to enforcement actions and jurisdictional considerations.
-
What is the significance of the patent landscape surrounding TW200521131?
The landscape indicates a competitive environment with overlapping patents, especially in chemical and pharmaceutical areas, necessitating strategic patent prosecution and freedom-to-operate analyses.
-
Is TW200521131 still enforceable, and what is its expiry date?
As a patent granted in 2005, its legal expiration typically occurs around 2025 unless extended or affected by legal invalidity procedures. Continuous status verification is advised.
References
- Official Taiwan Patent Database — [Patent TW200521131]
- Taiwan Intellectual Property Office (TIPO) — Patent law and procedural guidelines
- WIPO Patent Landscape Reports — Focused on pharmaceutical patents
- GlobalData Patent Analytics — Comparative patent landscape insights
